251 related articles for article (PubMed ID: 9019774)
1. [Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].
Shmelev EI; Stepanian IE
Probl Tuberk; 1996; (6):57-60. PubMed ID: 9019774
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic plasmapheresis in patients with destructive pulmonary tuberculosis].
Karpova NL; Naumov VN; Shaĭkhaev AIa; Titiukhina MV; Sigaev AT; Enilenis II
Probl Tuberk Bolezn Legk; 2006; (6):14-7. PubMed ID: 16881228
[TBL] [Abstract][Full Text] [Related]
3. [Clinical manifestations and specific features of the course of adenogenic tuberculosis in adults].
Ozerova LV; Zaĭtseva IP; Chistiakova NA
Probl Tuberk; 2003; (3):42-5. PubMed ID: 12744064
[TBL] [Abstract][Full Text] [Related]
4. [Follow-up of antitubercular treatment].
Gavira R; Gómez F; Otero MJ; Barrueco M; Domínguez-Gil A
Rev Clin Esp; 1994 Sep; 194(9):677-81. PubMed ID: 7984795
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].
Mizutani H; Horiba M; Shindoh J; Kimura T; Son M; Wakahara K
Kekkaku; 2001 Oct; 76(10):667-72. PubMed ID: 11712388
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
7. [Administration of antituberculous drugs to subjects with basic diseases. 3. Clinical studies on the side effects of antituberculous drugs in patients with or without basic diseases, especially drug allergy].
Onaka A
Kekkaku; 1987 Dec; 62(12):672-5. PubMed ID: 3448353
[No Abstract] [Full Text] [Related]
8. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
Gergert VIa; Rusakova LI
Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056
[TBL] [Abstract][Full Text] [Related]
9. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)].
Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917
[No Abstract] [Full Text] [Related]
12. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
Akbri MZ; Fatima N; ul Haque E; Shiekh AS; Bhatti MS
J Ayub Med Coll Abbottabad; 2001; 13(2):5-10. PubMed ID: 11732224
[TBL] [Abstract][Full Text] [Related]
13. [The use of plasmapheresis in treating the broncho-obstructive syndrome in patients with pulmonary tuberculosis].
Shmelev EI; Draganiuk AK
Probl Tuberk; 1992; (11-12):39-42. PubMed ID: 1289886
[TBL] [Abstract][Full Text] [Related]
14. [Adverse reactions of antituberculous agents, especially about its onset and duration].
Yamada H; Yasuoka A; Sasayama K; Doutsu Y; Hayashi T; Kohno S; Yamaguchi K; Hirota M; Hara K
Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434
[TBL] [Abstract][Full Text] [Related]
15. [Frequency, pattern, and diagnosis of adverse reactions in patients with pulmonary tuberculosis during chemotherapy with leading drugs].
Mishin VIu; Vasil'eva IA; Makieva VG; Kuz'mina NV; Prikazchikova AV; Khoroshutina VV
Probl Tuberk Bolezn Legk; 2003; (7):24-9. PubMed ID: 12939872
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria].
Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR
Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553
[TBL] [Abstract][Full Text] [Related]
17. [Immunological correction in progressive pulmonary tuberculosis].
Maslennikov AA; Kamenev VF; Kolomiets VM
Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
[TBL] [Abstract][Full Text] [Related]
18. [Early and late results of treatment of patients with tuberculosis shedding mycobacteria with primary resistance to basic antituberculous drugs].
Dubrawska H; Gryziecka T; Maceluch-Wojtkowa M; Orzechowska W
Wiad Lek; 1968 Jan; 21(2):77-80. PubMed ID: 5671874
[No Abstract] [Full Text] [Related]
19. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs].
Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS
Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643
[TBL] [Abstract][Full Text] [Related]
20. [EFFERENT THERAPY IN THE TREATMENT OF PATIENTS WITH DRUG-RESISTANT PULMONARY TUBERCULOSIS].
Tuberk Biolezni Legkih; 2010; (3):28-33. PubMed ID: 27529955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
